Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You keep ignoring one crucial piece of information. The company expects to conclude RI by the end of 2017. This means interim should happen very soon. Otherwise there won't be enough time for the rest of events to occur prior to the end of 2017.
If it is 38% would it be enough for DMC to recommend termination of study due to high efficacy?
Why everyone is ignoring the fact that the company keeps repeating that RI will run to completion in 2017. It's unlikely that it will be stopped at interim.
I truly hope our miserly ends this year, but management certainly doesn't think so.
The issue was FDA was looking for every possible way to screw amarin. They even came up with the idea that mineral oil that was used as a plasibo in amrn trials is not inert.
Unfortunately the people working for FDA are both stupid and corrupt. The idea that the wash out period simply wasn't long enough didn't even cross their minds.
Because the company is not for sale until RI results are out.
This post reminds me of those guys who were screaming back in 2012, BO $30 with NCE $20 without.
Converted options into shares.
He didn't.
Just be patient. The closer we get to interim the higher the pps is going to be.
It's called controlled accumulation.
The mineral oil is inert. The washout period wasn't long enough that's why the numbers in the control group were skewed. The mineral oil issue is a complete nonsense just like the ADCOM was a complete circus.
And you need to swallow 8 of them every day to get 4g EPA.
FDA will finish us then.
I don't think so....
"@stephenrosenman: @Phoenixrising @Amarin_Investor Not missing, too busy counting $$$"
Makes sense. Thank you for the clarification.
And what is your take on the interim now? Do you still think it will occur sometime this summer?
My guess is FDA will wait until RI interim data and then decide on allowing Anchor data on label.
I'm on board with you with my 70k shares.
It's very simple. Remember JZ and his $30 price tag on AMRN? Management's greed that's why.
How about Sun Trust upgrade and $6 conservative PT.
I think mid 2015 is a streach. The better V works (less events) the longer it will take to trigger interim analysis.
Pps jumping 800% in one day is another wet dream.
Because AMRN management is greedy. Remember not a penny under $30. They are ready to risk everything on RI, but won't invest their own money. Even here @$1.
$6bill - is too high, $2bill - is too low, that's why our market cap is $185mil. Great!
Seriously. He would be much better for us than JT & company.
Good! We won't miss her!
And if BP refuses to pay what AMRN wants just like years ago. What's then? Huge dilution to market new indications?
Hopefully our shares won't expire worthless one day;)
Ok, this is ambitious now.
It's fake.
He's no longer with the company so technically not an insider.
Frank was pumping hard back then. Now he's selling every single day...
There was some news on similar technology. But nothing specific on NVIV or Jordan. Probably someone just jumped a gun and shorts panicked. If no follow up news tomorrow we go down again.
Me too. But it keeps going down on decent volume. Not a very good sign.
What do you think where it will find a bottom? Is it going back to 50 cents?
Then it's not just me. Look at all the shares being sold in the past 2 weeks. Investors are walking away.
I don't know but more than that.
I was hoping for more than "custom wheelchair". I sincerely wish him all the best and that he won't need that chair after all.
"He's anxiously waiting for his custom wheelchair" - is not exactly what NVIV shareholders want to hear.
I don't know. It's just how I feel.
I'm not sure about that. This stock moves on news.
But anyway good luck to you, all NVIV shareholders, and Jordan of course.